Maine

Maine enacted LD 2110, "An Act to Update Employer Substance Use Testing Policy Requirements" (Public Law 2025, chapter 666), rewriting 26 MRSA §§681-683 for every employer that tests. A confirmed positive result may now be reported to an employer only by a medical review officer — a licensed physician who must act independently and hold clinical experience in controlled substance use disorders (§683, sub-§§7-A and 8, ¶E). The former "positive test result" is renamed "non-negative test result," and an applicant or employee must be given the opportunity to contest one by presenting a legitimate medical explanation to the MRO or confirmation laboratory before it is reported (§683, sub-§8, ¶B-1). The Act also confirms that Department of Labor authorization is required for any testing program and that an employer subject to federal testing requirements must test its non-federally-mandated employees in the same manner as its federally mandated ones. Employers governed by a federally mandated program — including DOT testing under the Omnibus Transportation Employee Testing Act — remain outside the subchapter under §681, sub-§8.